Research programme: transdermal Parkinson's disease therapeutics - Corium International

Drug Profile

Research programme: transdermal Parkinson's disease therapeutics - Corium International

Alternative Names: Corplex ropinirole - Corium International; Pramipexole TDS - Corium International; Pramipexole transdermal - Corium International; Ropinirole TDS - Corium International; Ropinirole transdermal - Corium International

Latest Information Update: 17 Feb 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Corium International
  • Class Amines; Benzothiazoles; Indoles; Small molecules
  • Mechanism of Action Dopamine D2 receptor agonists; Dopamine D3 receptor agonists; Dopamine D4 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Parkinson's disease

Most Recent Events

  • 01 Dec 2014 Preclinical trials in Parkinson's disease in USA (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top